The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 31, 2016

Filed:

Sep. 19, 2011
Applicants:

Mildred Enid Acevedo-duncan, Plant City, FL (US);

Diondra Denise Hill, Tampa, FL (US);

David A. Ostrov, Gainesville, FL (US);

Inventors:

Mildred Enid Acevedo-Duncan, Plant City, FL (US);

Diondra Denise Hill, Tampa, FL (US);

David A. Ostrov, Gainesville, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/66 (2006.01); A61K 31/675 (2006.01); A61K 31/4164 (2006.01); A61K 31/7088 (2006.01); A61K 39/395 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
A61K 31/675 (2013.01); A61K 31/4164 (2013.01); A61K 31/66 (2013.01); A61K 31/7088 (2013.01); A61K 39/39558 (2013.01); C12N 15/1137 (2013.01); C12Y 207/11013 (2013.01); C12N 2310/14 (2013.01);
Abstract

The subject invention pertains to uses of PKC-iota inhibitors for treatment of breast cancer. In one embodiment, the subject invention provides novel uses of 1H-imidazole-4-carboxamide, 5-amino-1-[2,3-dihydroxy-4-[(phosphonooxy)methyl]cyclopentyl]-,[1R-(1α, 2β, 3β, 4α)] (ICA-1) and related compounds for treatment of breast cancer. The compounds of the subject invention have potent anti-proliferative effects against human breast cancer cells. The compounds of the subject invention also inhibit the phosphorylation of IKK-α/IKK-β, induce chromatin condensation, and/or induce DNA fragmentation in cancer cells.


Find Patent Forward Citations

Loading…